Genetic Studies of Early-onset Dementia
Recruiting
Observational Study
Dementia, Early Onset
Alzheimer Dementia (AD)
Mild Cognitive Impairment (MCI)
Memory Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Columbia University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* 35 years and older
* Individuals experiencing memory concerns or diagnosed with dementia and their family members that are unrelated healthy controls without dementia.
Exclusion Criteria:
\- Individuals with competing diagnosis such as Huntington's disease, traumatic brain i…
Contacts